CESSATION THERAPEUTICS

Cessation Therapeutics provides therapeutics for an addiction-free through immunotherapy-based biotech innovation. Cessation Therapeutics is developing novel immunotherapy vaccine candidates and small molecules with the objective of helping millions of families overcome the opioid, heroin, morphine, fentanyl, alcohol and nicotine addiction use disorders. Cessation Therapeutics is currently developing heroin, opioid and fentanyl addiction vaccines based on the technology licensed from The Scripps Research Institute in La Jolla, California (TSRI) and has commenced planning pre-clinical studies to advance these vaccine candidates into clinical stage.